← All organizations

Aravive Biologics

For profitWebsite ↗

Also known as: Aravive Biologics | Aravive Biologics Inc | Aravive Biologics, Inc. | Aravive, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Dec 31, 2023

Timeline

2010s

Jan 1, 2016
Aravive Biologics— Founded
Jun 4, 2018
Versartis Inc.— Acquired

Drugs by trial phase (10 distinct, 18 trials)

Phase 3 (2 own, 2 via acquisition)

Phase 2 (5 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

carboplatin

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Versartis Inc.

Recent trials (15)

NCT05826015CollaboratorPhase 1Dec 31, 2023
NCT04983407Lead sponsorPhase 1/Phase 2Jul 28, 2021
NCT04983407Study directorPhase 1/Phase 2Jul 28, 2021
NCT04729608Study directorPhase 3Apr 22, 2021
NCT04729608Lead sponsorPhase 3Apr 22, 2021
NCT04300140Lead sponsorPhase 1/Phase 2Mar 31, 2020
NCT04300140Study directorPhase 1/Phase 2Mar 31, 2020
NCT04042623Lead sponsorPhase 2Nov 30, 2019
NCT04042623Study directorPhase 2Nov 30, 2019
NCT04019288CollaboratorPhase 1/Phase 2Oct 31, 2019
NCT04004442CollaboratorPhase 2Sep 30, 2019
NCT03639246Study directorPhase 1/Phase 2Oct 31, 2018
NCT03639246Lead sponsorPhase 1/Phase 2Oct 31, 2018
NCT03607955CollaboratorPhase 1Oct 31, 2018
NCT03401528Lead sponsorPhase 1Jan 31, 2018

Details

Founded: Houston, TX, US Jan 1, 2016
Last known activity: Dec 31, 2023